JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson Wiener Boerse

Equities

JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 04:00:55 2024-07-03 EDT			5-day change	1st Jan Change
135.7 ^EUR	-0.77%		-1.10%	-3.46%

07-02	J&J: promising results in multiple myeloma	CF
07-02	Johnson & Johnson Says Interim Analysis of Blood Cancer Therapy Study Show Promise	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	19-11-27
JOHNSON & JOHNSON :The underlying trend is to the upside	17-06-12
JOHNSON & JOHNSON :Expect the comeback of a strong trend	17-05-10
JOHNSON & JOHNSON :Buying pressure	16-12-22
JOHNSON & JOHNSON :A good level to buy	16-09-12
JOHNSON & JOHNSON :Towards historic highs	12-09-26
JOHNSON & JOHNSON :Beginning of a bearish movement	12-06-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm

Protect and grow your investments with the help of our experts

Securing my Investments

fermer